Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ana Christina Garrido-Castro, M.D.

Concepts (128)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoadjuvant Therapy7202428210.660 Why?
Breast Neoplasms, Male120202190.640 Why?
Trinitrotoluene1201860.620 Why?
Receptor, erbB-25202425530.600 Why?
Aminopyridines220235700.590 Why?
Morpholines120205800.580 Why?
Breast Neoplasms122024209850.550 Why?
Class I Phosphatidylinositol 3-Kinases120208970.530 Why?
Neoplasm Recurrence, Local6202392670.410 Why?
Receptors, Estrogen3202422040.380 Why?
Molecular Targeted Therapy3202428050.380 Why?
Patient Selection1201942400.270 Why?
Genomics3202358060.260 Why?
Mammary Neoplasms, Animal120221240.200 Why?
Antineoplastic Combined Chemotherapy Protocols32024117290.190 Why?
Neoplasm Metastasis3202449030.190 Why?
Immunohistochemistry22024110700.180 Why?
Camptothecin120235900.170 Why?
Inflammatory Breast Neoplasms120211470.170 Why?
Prognosis72024295510.160 Why?
Neoplasm Staging22024110960.150 Why?
Albumins120205750.150 Why?
Paclitaxel2202317320.140 Why?
Biological Therapy120181410.140 Why?
Survival Rate32020126980.140 Why?
Lymphatic Metastasis2202129120.130 Why?
Immunoconjugates120239530.130 Why?
Proto-Oncogene Proteins c-akt1202424530.130 Why?
Endocrine System Diseases120182490.130 Why?
Protein Kinase Inhibitors3202456620.120 Why?
Immunotherapy5202446490.120 Why?
Carboplatin120187930.120 Why?
Neoplasms, Second Primary1202210510.120 Why?
Lupus Vasculitis, Central Nervous System12014320.120 Why?
PTEN Phosphohydrolase1202011140.110 Why?
Female2120243918750.110 Why?
Inositol120142150.110 Why?
Humans3020247604370.100 Why?
Bone Marrow Cells1201824160.090 Why?
Kaplan-Meier Estimate1202064710.090 Why?
Communicable Diseases120188790.080 Why?
Cell Lineage1201825390.080 Why?
Combined Modality Therapy2202185220.080 Why?
Parietal Lobe120148500.080 Why?
Middle Aged920242203820.080 Why?
High-Throughput Nucleotide Sequencing1202036310.080 Why?
Genetic Testing1202135350.070 Why?
Aged, 80 and over22024588590.070 Why?
Treatment Outcome32024645910.070 Why?
Aged520241688400.070 Why?
Proteomics1202038180.070 Why?
Adult620242207810.070 Why?
Young Adult22024590680.070 Why?
Hematopoietic Stem Cells1201833960.060 Why?
Disease Progression22020134840.060 Why?
Mutation22020300250.060 Why?
Melanoma1202357040.060 Why?
Decision Making1201739230.050 Why?
Gene Expression Profiling1201994100.050 Why?
Biology120242890.050 Why?
Ki-67 Antigen120236290.050 Why?
Antibodies, Monoclonal1201891760.050 Why?
Biopsy2202467650.050 Why?
Phthalazines120233820.050 Why?
Antineoplastic Agents22021136160.040 Why?
Drug Synergism1202417550.040 Why?
Purines120236050.040 Why?
Genetic Predisposition to Disease12021178540.040 Why?
Tumor Microenvironment2202238740.040 Why?
BRCA2 Protein120237990.040 Why?
Observer Variation1202426040.040 Why?
Retrospective Studies22024804300.040 Why?
Endocrine Glands120181020.040 Why?
BRCA1 Protein1202311460.030 Why?
Xenograft Model Antitumor Assays1202435900.030 Why?
Survival Analysis22021100750.030 Why?
Antigens, Neoplasm1202319940.030 Why?
Granulocyte Colony-Stimulating Factor120186290.030 Why?
Mice42024814020.030 Why?
Cell Line, Tumor22024169450.030 Why?
Germ-Line Mutation1202318500.030 Why?
Signal Transduction12018233970.030 Why?
Lymphocytes, Tumor-Infiltrating1202010890.030 Why?
Osteoclasts120187110.030 Why?
Cell Differentiation22024115260.030 Why?
Breast1202219620.030 Why?
Animals520241682530.030 Why?
Immunocompromised Host120188550.030 Why?
Immunologic Factors1202115880.030 Why?
Adolescent12020881960.030 Why?
Mice, Nude1201836030.020 Why?
Communicable Disease Control120188480.020 Why?
Epigenesis, Genetic1202237820.020 Why?
Atrophy1201416310.020 Why?
Hematopoiesis1201820490.020 Why?
Quinazolines1201513710.020 Why?
Nuclear Proteins1202357940.020 Why?
DNA Methylation1202243830.020 Why?
Receptors, Cell Surface1201828190.020 Why?
Mass Spectrometry1201521890.020 Why?
Neoplasm Proteins1202036100.020 Why?
Bone Marrow1201829070.020 Why?
Consensus1201831150.020 Why?
Multivariate Analysis12021120540.020 Why?
Enzyme Inhibitors1201837100.020 Why?
Vascular Endothelial Growth Factor A1201834860.020 Why?
Proportional Hazards Models12021124290.020 Why?
CD8-Positive T-Lymphocytes1202045750.020 Why?
Temporal Lobe1201416900.020 Why?
Bone Neoplasms1201825250.020 Why?
Up-Regulation1201441160.020 Why?
Predictive Value of Tests12021152570.010 Why?
Gene Expression Regulation, Neoplastic1202085190.010 Why?
Transcription Factors12023121210.010 Why?
Macrophages1201857640.010 Why?
Male120203600350.010 Why?
Clinical Trials as Topic1201879960.010 Why?
Immunosuppressive Agents1201441680.010 Why?
Randomized Controlled Trials as Topic12018101800.010 Why?
Mice, Inbred C57BL12018221210.010 Why?
Incidence12018213220.010 Why?
Follow-Up Studies12020390780.010 Why?
Cohort Studies12020413660.010 Why?
Cognition1201469730.010 Why?
Prospective Studies12021543390.010 Why?
Time Factors12014399470.010 Why?
Neoplasms12018220830.000 Why?
Magnetic Resonance Imaging12014363620.000 Why?
Garrido-Castro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (84)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.